Header Logo

Connection

NICHOLAS MURPHY to Receptors, N-Methyl-D-Aspartate

Back to Details
This is a "connection" page, showing publications NICHOLAS MURPHY has written about Receptors, N-Methyl-D-Aspartate.
NICHOLAS MURPHY
Connection Strength
0.522
Receptors, N-Methyl-D-Aspartate
  1. Does mismatch negativity have utility for NMDA receptor drug development in depression? Braz J Psychiatry. 2022 Jan-Feb; 44(1):61-73.
    View in: PubMed
    Score: 0.180
  2. Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial. Depress Anxiety. 2021 11; 38(11):1108-1119.
    View in: PubMed
    Score: 0.174
  3. A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veterans. Neuropsychopharmacology. 2021 03; 46(4):820-827.
    View in: PubMed
    Score: 0.168
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.